Vimarsana
Biggest News Aggregation in the World

Page 2 - Keystone Symposium News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Keystone Symposium. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Keystone Symposium Today - Breaking & Trending Today

HOOKIPA Pharma : Reports Second Quarter 2022 Financial Results and Corporate Updates - Form 8-K - Vimarsana News

HOOKIPA Pharma : Reports Second Quarter 2022 Financial Results and Corporate Updates - Form 8-K

HOOKIPA Pharma Reports Second Quarter 2022 Financial Results and Corporate Updates ​ ● ... | August 11, 2022

The Daily Biotech Pulse: FDA Committee Backs Moderna Shot For 5-17 Years, 180 Life Sciences Stock Plunges, Pfizer's Posts Disappointing Paxlovid Data - Vimarsana News

The Daily Biotech Pulse: FDA Committee Backs Moderna Shot For 5-17 Years, 180 Life Sciences Stock Plunges, Pfizer's Posts Disappointing Paxlovid Data

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Pfizer Halts Enrollment In Paxlovid COVID-...

Akero Therapeutics to Present at Keystone Symposium on Efruxifermin as a Therapy for NASH - Vimarsana News

Akero Therapeutics to Present at Keystone Symposium on Efruxifermin as a Therapy for NASH

SOUTH SAN FRANCISCO, Calif., June 13, 2022 -- Akero Therapeutics, Inc. , a clinical-stage company developing transformational treatments for patients with serious metabolic diseases... | June 13, 2022

"She was the best of us" - Vimarsana News

"She was the best of us"

"She was the best of us" - IAVI. At the Annual Scientific Retreat in 2016 for the Duke Center for HIV/AIDS Vaccine Immunology

Source: iavi.org
UAE: When women consciously chose to stay-at-home - Vimarsana News

UAE: When women consciously chose to stay-at-home

UAE: When women consciously chose to stay-at-home Nandini Sircar/Dubai Supplied photo Reena returned to India in 2007 and rejoined Ranbaxy, while her family grew. Transitioning from a researcher to a homemaker was not easy for Reena Khan, who holds a doctorate in biochemistry. Leaving her illustrious career at a top Indian pharmaceutical company was a hard enough choice, she said. “Initially, I spent two years at Ranbaxy Gurgaon. I then got an opportunity to present a research paper on atherosclerosis at Keystone Symposium in Colorado, USA, in 2005. They liked my work and I was then offered...